The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(benzo[d]thiazol-2-yl)-1-butyl-6-ethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione ID: ALA1097961
PubChem CID: 46886648
Max Phase: Preclinical
Molecular Formula: C18H18N6O2S
Molecular Weight: 382.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCn1nc(-c2nc3ccccc3s2)nc2c(=O)n(CC)c(=O)nc1-2
Standard InChI: InChI=1S/C18H18N6O2S/c1-3-5-10-24-15-13(17(25)23(4-2)18(26)21-15)20-14(22-24)16-19-11-8-6-7-9-12(11)27-16/h6-9H,3-5,10H2,1-2H3
Standard InChI Key: IBLXRLVHYKSNTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
13.8532 0.1232 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.5201 -0.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2680 -1.1456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4430 -1.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1866 -0.3629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8920 -1.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0848 -1.5911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8284 -0.8069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3794 -0.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8105 -0.3499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2361 0.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2349 0.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9479 1.2920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6633 0.8828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6641 0.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3794 -0.3550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0944 0.0598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0896 0.8898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3737 1.2970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8016 1.3066 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3811 -1.1800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9455 2.1170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6587 2.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6562 3.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3695 3.7712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8137 -1.1749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9497 -0.3610 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
14 13 1 0
13 11 1 0
1 5 1 0
6 7 1 0
14 15 1 0
7 8 2 0
15 16 1 0
8 9 1 0
16 17 1 0
5 9 2 0
17 18 1 0
4 6 2 0
18 19 1 0
19 14 2 0
18 20 2 0
1 2 1 0
16 21 2 0
17 10 1 0
2 3 2 0
13 22 1 0
11 12 2 0
22 23 1 0
3 4 1 0
23 24 1 0
12 2 1 0
12 27 1 0
24 25 1 0
27 15 2 0
10 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 382.45Molecular Weight (Monoisotopic): 382.1212AlogP: 2.40#Rotatable Bonds: 5Polar Surface Area: 95.56Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.15CX LogP: 2.98CX LogD: 2.98Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -1.76
References 1. Zhou Y, Liu G, Chen J, Reddy PS, Yoon IS, Zhang M, Zhang B, Barber JR, Ng SC.. (2009) Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: their cytoprotection effect from rotenone toxicity and preliminary DMPK properties., 19 (21): [PMID:19786349 ] [10.1016/j.bmcl.2009.09.021 ]